UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
P27348 (1433T_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 14-3-3 protein theta; 14-3-3 protein T-cell; 14-3-3 protein tau; Protein HS1; | |
P63104 (1433Z_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 14-3-3 protein zeta/delta; Protein kinase C inhibitor protein 1; | |
P63151 (2ABA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform; PP2A subunit B isoform B55-alpha; PP2A subunit B isoform PR55-alpha; PP2A subunit B isoform R2-alpha; PP2A subunit B isoform alpha; | |
Q00005 (2ABB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform; PP2A subunit B isoform B55-beta; PP2A subunit B isoform PR55-beta; PP2A subunit B isoform R2-beta; PP2A subunit B isoform beta; | |
Q66LE6 (2ABD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform; PP2A subunit B isoform B55-delta; PP2A subunit B isoform PR55-delta; PP2A subunit B isoform R2-delta; PP2A subunit B isoform delta; | |
Q9Y2T4 (2ABG_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform; IMYPNO1; PP2A subunit B isoform B55-gamma; PP2A subunit B isoform PR55-gamma; PP2A subunit B isoform R2-gamma; PP2A subunit B isoform gamma; | |
P14060 (3BHS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I; 3-beta-hydroxy-5-ene steroid dehydrogenase; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase; 3-beta-hydroxysteroid 3-dehydrogenase; Delta-5-3-ketosteroid isomerase; Dihydrotestosterone oxidoreductase; Steroid Delta-isomerase; Trophoblast antigen FDO161G; | |
P26439 (3BHS2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II; 3-beta-HSD adrenal and gonadal type; 3-beta-hydroxy-Delta(5)-steroid dehydrogenase; 1.1.1.145; 3-beta-hydroxy-5-ene steroid dehydrogenase; Progesterone reductase; Steroid Delta-isomerase; 5.3.3.1; Delta-5-3-ketosteroid isomerase; | |
Q9H2F3 (3BHS7_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 3 beta-hydroxysteroid dehydrogenase type 7; 3 beta-hydroxysteroid dehydrogenase type VII; 3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase; Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase; | |
Q7L8J4 (3BP5L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SH3 domain-binding protein 5-like; | |
O60239 (3BP5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SH3 domain-binding protein 5; SH3 domain-binding protein that preferentially associates with BTK; | |
P28222 (5HT1B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 1B; S12; Serotonin 1D beta receptor; Serotonin receptor 1B; | |
P28221 (5HT1D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 1D; Serotonin 1D alpha receptor; Serotonin receptor 1D; | |
P28566 (5HT1E_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 1E; S31; Serotonin receptor 1E; | |
P30939 (5HT1F_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 1F; Serotonin receptor 1F; | |
P28223 (5HT2A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 2A; Serotonin receptor 2A; | |
O95264 (5HT3B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3B; Serotonin receptor 3B; | |
Q8WXA8 (5HT3C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3C; Serotonin receptor 3C; | |
Q70Z44 (5HT3D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3D; Serotonin receptor 3D; | |
A5X5Y0 (5HT3E_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3E; Serotonin receptor 3E; | |
Q13639 (5HT4R_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 4; Serotonin receptor 4; | |
Q9Y6E2 (5MP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | eIF5-mimic protein 1; Basic leucine zipper and W2 domain-containing protein 2; | |
Q7L1Q6 (5MP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | eIF5-mimic protein 2; Basic leucine zipper and W2 domain-containing protein 1; Protein Orf; | |
Q9BXI3 (5NT1A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Cytosolic 5'-nucleotidase 1A; 5'-deoxynucleotidase; Cytosolic 5'-nucleotidase IA; | |
P05408 (7B2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuroendocrine protein 7B2; Pituitary polypeptide; Secretogranin V; Secretogranin-5; Secretory granule endocrine protein I; N-terminal peptide; C-terminal peptide; | |
P02763 (A1AG1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-1-acid glycoprotein 1; Orosomucoid-1; | |
P19652 (A1AG2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-1-acid glycoprotein 2; Orosomucoid-2; | |
P20848 (A1ATR_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-1-antitrypsin-related protein; Protease inhibitor 1-like; Serpin A2; | |
P22760 (AAAD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Arylacetamide deacetylase; | |
P01011 (AACT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-1-antichymotrypsin; Cell growth-inhibiting gene 24/25 protein; Serpin A3; Alpha-1-antichymotrypsin His-Pro-less; | |
Q8N5Z0 (AADAT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial; 2-aminoadipate aminotransferase; 2-aminoadipate transaminase; Alpha-aminoadipate aminotransferase; Glycine transaminase AADAT; Kynurenine aminotransferase II; Kynurenine--glyoxylate transaminase AADAT; Kynurenine--oxoglutarate aminotransferase II; Kynurenine--oxoglutarate transaminase 2; Kynurenine--oxoglutarate transaminase II; Methionine--glyoxylate transaminase AADAT; | |
Q13685 (AAMP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Angio-associated migratory cell protein; | |
Q9Y312 (AAR2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein AAR2 homolog; AAR2 splicing factor homolog; | |
Q9BTE6 (AASD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alanyl-tRNA editing protein Aarsd1; Alanyl-tRNA synthetase domain-containing protein 1; | |
Q8NHS2 (AATC2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative aspartate aminotransferase, cytoplasmic 2; Glutamate oxaloacetate transaminase 1-like protein 1; Transaminase A-like protein 1; | |
P17174 (AATC_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Aspartate aminotransferase, cytoplasmic; Cysteine aminotransferase, cytoplasmic; Cysteine transaminase, cytoplasmic; Glutamate oxaloacetate transaminase 1; Transaminase A; | |
P00505 (AATM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Aspartate aminotransferase, mitochondrial; Fatty acid-binding protein; Glutamate oxaloacetate transaminase 2; Kynurenine aminotransferase 4; Kynurenine aminotransferase IV; Kynurenine--oxoglutarate transaminase 4; Kynurenine--oxoglutarate transaminase IV; Plasma membrane-associated fatty acid-binding protein; Transaminase A; | |
Q9NRW3 (ABC3C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DNA dC->dU-editing enzyme APOBEC-3C; APOBEC1-like; Phorbolin I; | |
Q96AK3 (ABC3D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DNA dC->dU-editing enzyme APOBEC-3D; | |
Q6NTF7 (ABC3H_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DNA dC->dU-editing enzyme APOBEC-3H; APOBEC-related protein 10; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H; | |
Q8N2K0 (ABD12_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Lysophosphatidylserine lipase ABHD12; 2-arachidonoylglycerol hydrolase ABHD12; Abhydrolase domain-containing protein 12; Monoacylglycerol lipase ABHD12; Oxidized phosphatidylserine lipase ABHD12; | |
Q0P651 (ABD18_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD18; Alpha/beta hydrolase domain-containing protein 18; | |
P41238 (ABEC1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C->U-editing enzyme APOBEC-1; Apolipoprotein B mRNA-editing enzyme catalytic subunit 1; HEPR; mRNA(cytosine(6666)) deaminase 1; | |
Q9Y235 (ABEC2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C->U-editing enzyme APOBEC-2; mRNA(cytosine(6666)) deaminase 2; | |
Q8WW27 (ABEC4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative C->U-editing enzyme APOBEC-4; Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 4; | |
Q6UXT9 (ABH15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD15; Alpha/beta hydrolase domain-containing protein 15; | |
Q96SE0 (ABHD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD1; Alpha/beta hydrolase domain-containing protein 1; Lung alpha/beta hydrolase 1; | |
Q8WU67 (ABHD3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phospholipase ABHD3; Abhydrolase domain-containing protein 3; | |
Q96I13 (ABHD8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD8; Alpha/beta hydrolase domain-containing protein 8; | |
Q96IU4 (ABHEB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative protein-lysine deacylase ABHD14B; Alpha/beta hydrolase domain-containing protein 14B; CCG1-interacting factor B; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_02 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
20,598 | 17,358 | 42,928 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 55-mer | 56-mer | 60-mer | 62-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38,419 | 3,200 | 302 | 594 | 64 | 118 | 14 | 57 | 3 | 29 | 11 | 38 | 1 | 3 | 22 | 4 | 2 | 1 | 1 | 16 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 1 | 1 | 4 | 2 | 4 | 4 | 2 |